Skip to content Skip to footer

Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Langgan

Surat Berita

订阅我们的月讯

Subscribe to our

Newsletter